NSE · SYNCOMF
Syncom Formulations (India) Limited (SYNCOMF) Share Price
Historical price visualisation is temporarily undergoing corporate data-licensing maintenance. Full interactive price and chart data will return following our upcoming authorized NSE/BSE data-feed deployment. Derived metrics (valuation ratios, market-cap rank), company financials, shareholding, corporate actions, and mutual-fund holdings remain available.
Market cap rank
#1,228
of 5,047 stocks
▲ 151W▼ 181M
Peak #1,155 · 02 Oct 2026
Syncom Formulations (India) Limited is a smallcap company in the Healthcare space and is growing revenue modestly, commands a premium earnings multiple, and earns a healthy return on equity.
Market Cap
1,991.86 Cr
P/E Ratio
26.16
P/B Ratio
4.80
ROE
18.42%
ROCE
23.77%
Dividend Yield
—
52W High
—
52W Low
—
Quarterly financials
| Metric | Q2 2026-27 | Q1 2026-27 | Q4 2025-26 | Q3 2025-26 |
|---|---|---|---|---|
| Revenue | 142.14 Cr | 125.53 Cr | 135.41 Cr | 115.14 Cr |
| Net Profit | 26.65 Cr | 24.85 Cr | 25.17 Cr | 18.91 Cr |
| EPS | 0.28 | 0.26 | 0.27 | 0.23 |
| Operating Profit | 36.43 Cr | 32.50 Cr | 34.08 Cr | 25.35 Cr |
Shareholding pattern
Promoter
50.57%
Public
49.43%
PUBLIC BREAKDOWN
FII
0.35%
DII
0.00%
MF (within DII)
0.00%
Individuals
46.70%
Mutual fund holdings
₹0.04
Cr total
2
Schemes
2
Fund Houses
₹0.04 Cr
Total Exposure
Motilal Oswal Mutual Fund₹0.02 Cr (67.6%)
Bandhan Mutual Fund₹0.01 Cr (32.4%)
| Scheme | Fund House | Value (Cr) | % |
|---|
Recent corporate actions
| Ex-Date | Type | Details |
|---|---|---|
| 23 Sep 2024 | Other | Annual General Meeting |
| 18 Sep 2023 | Other | Annual General Meeting |
Other Healthcare stocks
Need this data in your app?
Full price history, technical indicators, and every field above via one REST API call.